Apr 30, 2013
Stellar Biotechnologies, Inc. ("Stellar" or “the Company”) (OTCQB: SBOTF) (TSX-V: KLH), the world leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), today announced publication o...
Mar 19, 2013
Stellar Biotechnologies, Inc. ("Stellar" or “the Company”) (OTCQB: SBOTF) (TSX-V: KLH), the world leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), today announced the Company h...
Mar 13, 2013
Stellar Biotechnologies, Inc. ("Stellar" or “the Company”) (OTCQB: SBOTF) (TSX-V: KLH) today announced the presentation of results from a preclinical study of Keyhole Limpet Hemocyanin (KLH), condu...
Feb 19, 2013
Stellar Biotechnologies, Inc. ("Stellar" or “the Company”) (OTCQB: SBOTF) (TSX-V: KLH) today announced that the Company exceeded its 2012 plan to increase key stages of its aquaculture capacity to ...
Feb 6, 2013
Stellar Biotechnologies, Inc. ("Stellar" or “the Company”) (OTCQB: SBOTF) (TSX-V: KLH) today announced that the Company has submitted a provisional application for a patent to the U.S. Patent and T...
Jan 22, 2013
Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that the Company has successfully achieved a commercial-scale aquaculture system that su...
Jan 17, 2013
Stellar Biotechnologies, Inc. (“Stellar” or the “Company”) (OTCQB: SBOTF) (TSX-V: KLH), the world leader in sustainable manufacture of GMP-grade Keyhole Limpet Hemocyanin (KLH), today announced tha...
Jan 15, 2013
Stellar Biotechnologies, Inc. (“Stellar” or the “Company”) (OTCQB: SBOTF) (TSX-V: KLH), the world leader in sustainable manufacture of GMP-grade Keyhole Limpet Hemocyanin (KLH), is very pleased to ...
Jan 2, 2013
Stellar Biotechnologies, Inc. (“Stellar” or the “Company”) (TSX-V: KLH) (PINKSHEETS: SBOTF) (Frankfurt: RBT), the world leader in sustainable manufacture of GMP-grade Keyhole Limpet Hemocyanin (KLH...
Dec 12, 2012
Stellar Biotechnologies, Inc. (“Stellar” or the “Company”) (TSX-V: KLH) (PINKSHEETS: SBOTF) (Frankfurt: RBT), the world leader in sustainable manufacture of GMP-grade Keyhole Limpet Hemocyanin (KLH...
Nov 27, 2012
Stellar Biotechnologies, Inc. (“Stellar” or the “Company”) (TSX-V: KLH) (PINKSHEETS: SBOTF) (Frankfurt: RBT), the world leader in sustainable manufacture of GMP-grade Keyhole Limpet Hemocyanin (KLH...
Oct 31, 2012
Stellar Biotechnologies, Inc. (“Stellar” or the “Company”) (TSX-V: KLH) (PINKSHEETS: SBOTF) (Frankfurt: RBT), the world leader in sustainable manufacture of GMP-grade Keyhole Limpet Hemocyanin (KLH...
Oct 23, 2012
Stellar Biotechnologies, Inc. (“Stellar” or the “Company”) (TSX-V: KLH) (PINKSHEETS: SBOTF) (Frankfurt: RBT), the world leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), today a...
Oct 4, 2012
Stellar Biotechnologies, Inc. (“Stellar” or the “Company”) (TSX-V: KLH) (PINKSHEETS: SBOTF) (Frankfurt: RBT) is very pleased to announce the filing of a US Letters Patent Application directed to pr...
Sep 26, 2012
Stellar Biotechnologies, Inc. ("Stellar") (TSX-V: KLH) (PINKSHEETS: SBOTF) (Frankfurt: RBT) today announced that Frank Oakes, President and Chief Executive Officer of Stellar, presented at the 2nd ...
Aug 16, 2012
Stellar Biotechnologies, Inc. (“Stellar” or the “Company”) (TSX-V: KLH) (PINKSHEETS: SBOTF) (Frankfurt: RBT) is very pleased to announce that Gregory T. Baxter, Ph.D. and Mike Sampat have been appo...
Aug 9, 2012
Stellar Biotechnologies, Inc. ("Stellar") (TSX-V: KLH) (PINKSHEETS: SBOTF) (Frankfurt: RBT) is very pleased to announce that Herbert S. Chow, Ph.D. has been appointed to the position of Chief Techn...
Jun 25, 2012
Stellar Biotechnologies, Inc. ("Stellar") (TSX-V: KLH) (PINKSHEETS: SBOTF) (Frankfurt: RBT) is pleased to report that an abstract prepared by Stellar scientists on KLH immunobiology has been accept...
Jun 20, 2012
Stellar Biotechnologies, Inc. ("Stellar") (TSX-V: KLH) (PINKSHEETS: SBOTF) (Frankfurt: RBT) is pleased to announced that Stellar scientists will be presenting new KLH science at the ICAAC 2012 Conf...
Apr 25, 2012
Stellar Biotechnologies, Inc. ("Stellar") (TSX-V: KLH) (PINKSHEETS: SBOTF) (Frankfurt: RBT) announced today the launch of KLH Site™ at www.klhsite.com, the first website dedicated to scientific and...
Apr 10, 2012
Stellar Biotechnologies, Inc. ("Stellar") (TSX-V: KLH) (U.S. PINKSHEETS: SBOTF) (Frankfurt: RBT) today announced that it has entered into an agreement with the University of Guelph (Ontario, Canada...
Apr 3, 2012
Stellar Biotechnologies, Inc. ("Stellar") (TSX-V: KLH) (U.S. OTC: SBOTF) (Frankfort: RBT), the world leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), announced today the launch...
Mar 13, 2012
Stellar Biotechnologies, Inc. ("Stellar") (TSX-V: KLH) (U.S. OTC: SBOTF) (Frankfort: RBT) announced today that the Company has published an update to its corporate profile brochure.
Jan 4, 2012
Stellar Biotechnologies, Inc. ("Stellar") (TSX-V: KLH) (U.S. OTC: SBOTF) is pleased to announce that it will be making two presentations at the Biotech Showcase 2012 Conference in San Francisco Jan...
Dec 20, 2011
Stellar Biotechnologies, Inc. (TSX-V: KLH) (U.S. OTC: SBOTF) ("Stellar" or the "Company") is pleased to announce that it has adopted a shareholder rights plan (the "Rights Plan") designed to encour...
Dec 6, 2011
Stellar Biotechnologies, Inc. ("Stellar") (TSX-V: KLH) (U.S. OTC: SBOTF) is pleased to announce the completion of a major expansion of its keyhole limpet (megathura crenulata) hatchery facility in ...
Nov 22, 2011
PORT HUENEME, CA--(Marketwire - November 22, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to report two recent news stories on the company, by the Nat...
Nov 2, 2011
Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (U.S. OTC: SBOTF) is pleased to announce they have retained A.B. Korelin & Associates Inc. of Blaine, WA to assist the Company in its preparatio...
Oct 26, 2011
Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (U.S. OTC: SBOTF) and Life Diagnostics, Inc. are pleased to announce they have entered into an exclusive manufacturing and supply agreement. Lif...
Sep 20, 2011
Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (U.S. OTC: SBOTF) is pleased to announce they have received the first purchase order from Sigma-Aldrich under terms of the marketing agreement b...
Sep 12, 2011
Stellar Biotechnologies, Inc. "Stellar" (TSX-V:
KLH) (U.S. OTC: SBOTF) is pleased to announce they have entered into an agreement for
strategic business planning advisory services with LifeTech C...
Aug 29, 2011
PORT HUENEME, CA-- August 29, 2011 - Stellar Biotechnologies, Inc. "Stellar" (TSX-V:KLH) (U.S. OTC: SBOTF) is pleased to announce that the National Science Foundation (NSF) has granted Stellar a Ph...
Aug 3, 2011
PORT HUENEME, CA (August 3, 2011) -- Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH)
(U.S. OTC: SBOTF) is pleased to announce they have entered into an agreement for marketing
and sales with...
Jul 6, 2011
Stellar Biotechnologies, Inc. “Stellar” (TSX-V: KLH) (U.S. OTC: SBOTF) is pleased to announce that its President, Frank Oakes and Executive VP, Corporate Development & Finance, Darrell Brookstein r...
Jun 13, 2011
Stellar Biotechnologies, Inc. “Stellar” (TSX-V:
KLH) (U.S. OTC: SBOTF) is pleased to announce that its semi-annual CEO Letter to
Shareholders has been released.
May 24, 2011
Stellar Biotechnologies, Inc. (TSX-V: KLH)
(U.S. OTC: SBOTF) is very pleased to announce that it has appointed David L. Hill,
Ph.D. as a member of its board of directors.
May 10, 2011
Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) announces the completion of a pre-Investigational Device Exemption (pre-IDE) meeting with the U.S. Food and Drug Administration’s
Mar 8, 2011
Stellar Biotechnologies, Inc.
(PINKSHEETS: SBOTF) (TSX-V: KLH) has appointed Michael R. McClurg to VP, Business
Development & Marketing. His employment begins shortly, and Company Executive VP,...
Jan 25, 2011
Stellar Biotechnologies, Inc. (TSX-V: KLH) (PINKSHEETS:
SBOTF) is pleased to announce successful completion of preclinical toxicity and
immunogenicity testing of Stellar IMG KLH and Stellar Sub...
Dec 14, 2010
Stellar Biotechnologies, Inc. (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce that its U.S. subsidiary has been awarded a $99,000 grant from The National Science Foundation (NSF)
Dec 7, 2010
Stellar Biotechnologies, Inc. (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce that it has acquired an exclusive, irrevocable, worldwide, sub-licensable and royalty-free license to the techn...
Nov 30, 2010
Stellar Biotechnologies, Inc. (TSX-V: KLH) (PINKSHEETS: SBOTF) (www.StellarBiotechnologies.com) announces completion of preclinical toxicity and immunogenicity testing of Stellar KLH/SUBUNIT and St...
Nov 15, 2010
Stellar Biotechnologies, Inc. (the "Company" or “Stellar”) (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce that it has closed the non-brokered private placement announced on October 25, 201...
Nov 4, 2010
Stellar Biotechnologies, Inc. (the "Company" or “Stellar”, TSX.V: KLH - U.S. OTC: SBOTF) is pleased to announce that its California subsidiary received news this week that it has been awarded two g...
Oct 25, 2010
Stellar Biotechnologies, Inc. (the "Company" or “Stellar”, TSX.V: KLH) announces a non-brokered private placement financing consisting of up to 6,000,000 units (the “Units”) at a purchase price of ...
Oct 20, 2010
Stellar Biotechnologies, Inc. announced today that its California subsidiary has been invited to submit a formal application for funding under the National Science Foundation’s (NSF) Technology Enh...
Oct 13, 2010
Stellar Biotechnologies, Inc. (“Stellar” or “the Company”) has been advancing on several fronts over their first quarter as a public company, and expects to achieve new milestones before year end. ...
Sep 30, 2010
Stellar Biotechnologies, Inc. received payment of US$ 288,000 for a filled order of Stellar KLH/SUBUNIT from French biotechnology and active immunotherapy technology-platform company
Sep 29, 2010
Stellar Biotechnologies, Inc. (Stellar) is pleased to announce that it has agreed to complete a CDN$ 1.05M private placement subject to acceptance by the TSX Venture Exchange
Sep 13, 2010
Stellar Biotechnologies, Inc. is collaborating with Bayer Innovation GmbH (BIG) in the development of biopharmaceuticals.
Sep 9, 2010
Stellar Biotechnologies, Inc. (PINK SHEETS: SBOTF & TSX-V: KLH) announces filing for patent protection of inventions related to its native Immunogenic (IMG) KLH technology platform and immune statu...
Jul 12, 2010
Stellar Biotechnologies, Inc. is pleased to announce that eminent biochemist, Malcolm Gefter, Ph. D. has accepted appointment to both Stellar's Board of Directors and to its Scientific Advisory Boa...
Jun 29, 2010
Stellar Biotechnologies, Inc. (OTC: SBOTF - TSX-V: KLH) has appointed John S. Sundsmo, Ph.D., VP - Research & Intellectual Property Management and Daniel C. Adelman, M.D. as a member of the Scienti...
Jun 22, 2010
Stellar Biotechnologies, Inc. (OTC: SBOTF - TSX-V: KLH) is pleased to announce that it has released its new customer and investor-friendly website at www.StellarBiotechnologies.com.
Jun 10, 2010
Stellar Biotechnologies, Inc. (OTC: SBOTF - TSX-V: KLH) will initiate preclinical testing of its immunogenic agent, Stellar KLH/NeoA, in anticipation of filing an IND application for its Stellar KL...
Jun 1, 2010
Stellar Biotechnologies, Inc. (OTC: SBOTF, TSX-V: KLH) (“Stellar”) is pleased to announce that its long-term customer, Neovacs SA - Paris (Paris Alternext: ALNEV), recently reached significant mile...
May 18, 2010
Stellar Biotechnologies, Inc. (OTC: SBOTF, TSX-V: KLH) has appointed Herbert S. Chow, Ph.D., VP: Product Development.
May 11, 2010
Stellar Biotechnologies, Inc. (OTC: SBOTF, TSX-V: KLH) has appointed Dr. Andrew Saxon, a world-renowned expert in human cellular and molecular immunology, Chairman - SAB. Dr. Saxon is Professor & C...
Apr 28, 2010
Stellar Biotechnologies, Inc. (OTC: SBOTF, TSX-V: KLH) has appointed eminent scientist Daniel E. Morse, Ph. D. as Director and Executive VP: Science & Technology effective April 19, 2010.
Apr 14, 2010
CAG Capital Inc. (now Stellar Biotechnologies, Inc.) (OTC: SBOTF, TSX-V: KLH) (the “Company”) is pleased to announce the closing of the acquisition of Stellar Biotechnologies, Inc.
